共 50 条
[1]
Mountain CF(1997)Revisions in the international system for staging lung cancer Chest 111 1710-1717
[2]
Winton T(2005)Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer N Engl J Med 352 2589-2597
[3]
Livingston R(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719-727
[4]
Johnson D(2008)Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 3552-3559
[5]
Douillard JY(2005)Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes Lung Cancer 47 69-80
[6]
Rosell R(2003)Gemcitabine plus cisplatin vs gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial Lung Cancer 41 321-331
[7]
De Lena M(2003)Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer Lung Cancer 41 81-89
[8]
Pignon JP(1992)Predicting glomerular function from adjusted serum creatinine Nephron 62 249-256
[9]
Tribodet H(1989)Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1-10
[10]
Scagliotti GV(2001)Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial J Clin Oncol 19 3210-3218